AI-Driven De Novo Design and Molecular Modeling for Discovery of Small-Molecule Compounds as Potential Drug Candidates Targeting SARS-CoV-2 Main Protease

Over the past three years, significant progress has been made in the development of novel promising drug candidates against COVID-19. However, SARS-CoV-2 mutations resulting in the emergence of new viral strains that can be resistant to the drugs used currently in the clinic necessitate the developm...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrianov, Alexander M., Shuldau, Mikita A., Furs, Konstantin V., Yushkevich, Artsemi M., Tuzikov, Alexander V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178971/
https://www.ncbi.nlm.nih.gov/pubmed/37175788
http://dx.doi.org/10.3390/ijms24098083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178971/
https://www.ncbi.nlm.nih.gov/pubmed/37175788
http://dx.doi.org/10.3390/ijms24098083

Ejemplares similares